Tempest Therapeutics Inc. (NASDAQ: TPST) Stock Information | RedChip

Tempest Therapeutics Inc. (NASDAQ: TPST)


$0.9244
-0.0612 ( -5.67% ) 689.2K

Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.

Market Data


Open


$0.9244

Previous close


$0.9856

Volume


689.2K

Market cap


$40.26M

Day range


$0.9070 - $0.9850

52 week range


$0.6986 - $6.0000

SEC Filings


Form Type Description Pages Date
def Proxies and info statements 9 Apr 23, 2024
ars Annual reports 1 Apr 23, 2024
10-k Annual reports 78 Mar 19, 2024
8-k 8K-related 13 Mar 19, 2024
4 Insider transactions 2 Jan 05, 2024
4 Insider transactions 1 Jan 05, 2024
4 Insider transactions 1 Jan 05, 2024
4 Insider transactions 2 Jan 05, 2024

Latest News